Dextech Medical AB (NGM: DEX)

Dextech Medical AB Balance Sheet

Financials in millions SEK. Fiscal year is July - June.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2024	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021	Jun 30, 2020
Cash & Equivalents	17.99	19.04	25.24	35.47	3.46	6.09
Cash & Short-Term Investments	17.99	19.04	25.24	35.47	3.46	6.09
Cash Growth	-23.84%	-24.54%	-28.86%	926.20%	-43.25%	53887.79%
Other Receivables	-	0.13	0.11	0.2	0.03	0.03
Receivables	0.59	0.13	0.11	0.2	0.03	0.03
Other Current Assets	-	0.5	0.47	0.35	0.26	0.25
Total Current Assets	18.58	19.68	25.82	36.02	3.75	6.37
Long-Term Investments	0	0	0	0	0	0
Other Intangible Assets	10.57	0.25	0.25	0.39	0.54	0.51
Long-Term Deferred Charges	-	10.66	8.97	3.18	2.94	6.46
Total Assets	29.16	30.59	35.03	39.59	7.23	13.34
Accounts Payable	-	0.28	0.15	0.25	0.04	0.07
Accrued Expenses	-	0.69	0.55	0.43	0.15	0.15
Other Current Liabilities	0.69	0.01	0.02	0.03	0.03	0.03
Total Current Liabilities	0.69	0.98	0.72	0.71	0.22	0.25
Total Liabilities	0.69	0.98	0.72	0.71	0.22	0.25
Common Stock	28.47	0.83	0.83	0.83	0.67	0.67
Additional Paid-In Capital	-	105.2	105.2	105.2	68.22	68.22
Retained Earnings	-	-76.42	-71.71	-67.15	-61.88	-55.8
Shareholders' Equity	28.47	29.61	34.31	38.88	7.02	13.09
Total Liabilities & Equity	29.16	30.59	35.03	39.59	7.23	13.34
Net Cash (Debt)	17.99	19.04	25.24	35.47	3.46	6.09
Net Cash Growth	-23.84%	-24.54%	-28.86%	926.20%	-43.25%	53887.79%
Net Cash Per Share	0.96	1.01	1.37	2.09	0.23	0.41
Filing Date Shares Outstanding	18.49	18.49	18.49	18.49	14.92	14.92
Total Common Shares Outstanding	18.49	18.49	18.49	18.49	14.92	14.92
Working Capital	17.9	18.7	25.1	35.31	3.54	6.12
Book Value Per Share	1.54	1.60	1.86	2.10	0.47	0.88
Tangible Book Value	17.9	29.36	34.07	38.49	6.47	12.58
Tangible Book Value Per Share	0.97	1.59	1.84	2.08	0.43	0.84

Source: S&P Capital IQ. Standard template. Financial Sources.